학술논문
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Document Type
Article
Author
Schneider, C.; Baldauf, H.-M.; Schwarz, S.-M.; Stegmann, L.; Martin, M.; Keppler, O.T.; Cinatl, J.; Oellerich, T.; Cremer, A.; Lohmeyer, J.; Serve, H.; Comoglio, F.; Thomas, D.; Geisslinger, G.; Ferreirós, N.; Flick, R.; Yakunin, A.F.; Bohnenberger, H.; Ströbel, P.; Kaderali, L.; Michaelis, M.; Hornung, V.; Schliemann, C.; Berdel, W.E.; Hartmann, W.; Wardelmann, E.; Hansmann, M.-L.
Source
In: Nature Medicine . (Nature Medicine, 1 February 2017, 23(2):250-255)
Subject
Language
English
ISSN
1546170X
10788956
10788956